To investigate potential clinical value of measuring JAK-STAT1/2 and JAK-STAT3 pathway activity in patients with a viral infection, pathway activity was measured on public gene expression data from earlier clinical studies on infections with influenza, respiratory syncytial virus (RSV), dengue, yellow fever, rotavirus, and hepatitis B virus. This evidence concerns the gene STAT1 and viral infectious disease.